Normal cells have a variety of mechanisms that protect them from pathogens. Key players in cellular antiviral defenses are type 1 interferons (IFNs). In response to initial virus intrusion, IFNs signal surrounding cells and stimulate them to enter an antiviral state that includes restricted proliferation, downregulated metabolism, and other specific changes that restrict viral replication. 1, 2 Interferons also play an important role in immune surveillance, which reduces the probability of malignant transformation. 3 A malignant cell with dysfunctional IFN induction or response has numerous survival and growth advantages. Thus, accumulation of genetic defects in IFN signaling cascades and cancerogenesis go hand in hand. 4 Half of the silencing epigenetic changes associated with immortalization of cells belong to genes involved in IFN pathways. 5 The deletion of such genes is often observed in gliomas, 6 leukemias, 7 and bladder cancer. 8 Low expression of IFN receptors is characteristic of hepatocellular, 9, 10 pancreatic, 11 gastric, 12 colon rectal, 13 and many other cancers. 4 Moreover, immune cells of cancer patients often have impaired IFN signaling. 14 Thus, along with the importance of IFN pathways for cellular defense against viruses, defects in these pathways promote viral oncolysis. The purpose of this review is to describe the broad range of these defects along with their role in promotion of malignant cell sensitivity to oncolytic viruses.
| DEFECTIVE INDUCTION OF TYPE 1 IFNs IN CANCER CELLS
In normal cells, virus infection triggers an antiviral mechanism which consists of 2 phases. First, as a result of recognition of viral components, expression and secretion of type 1 IFNs are initiated. Interferons then interact with specific receptors and stimulate a second phase, the IFN response. During the second phase, the secretion of IFNs is additionally stimulated by a positive regulatory feedback loop. The induction of IFN production is triggered by a set of molecular events that includes the interaction of viral components with specific cellular receptors and their activation. The activated receptors form a complex with adaptor proteins, and this complex promotes phosphorylation of transcription factors.
Finally, the phosphorylated transcription factors move to the nucleus and initiate the transcription of IFN mRNAs, leading to production and secretion of IFNs. In cancer cells, this chain of molecular events might be broken at different levels and by a variety of mechanisms.
The genes of the IFN induction pathway whose defects have been shown to be associated with sensitivity to viruses are described below and listed in Table 1 . nize only viral DNA and some only viral RNA. Some PRRs recognize viral nucleic acids at the cell surface, even before the virus enters the cell, while others recognize viral components inside the cell. 33 
| Membrane-associated PRRs
Toll-like receptors (TLRs) are membrane-bound PRRs that initiate pathways for induction of IFNs and proinflammatory cytokines ( Figure 1 ). Toll-like receptors become activated after interaction with [36] [37] [38] [39] It is interesting that cytosolic viral RNA can also serve as cGAS activating ligand by forming DNA: RNA hybrid. 40 In general, it should be noted that some viral RNA intermediately transcribed from the cytoplasmic genome of a DNA virus can be also be recognized by cytosolic RNA sensors. [41] [42] [43] Moreover, DNA reverse transcribed from genomic RNA of retroviruses can be recognized by cytosolic DNA sensors. 44 
| A type 1 interferon autocrine-paracrine signal amplification loop
Receptors that recognize viral nucleic acids initiate signaling cascades that lead to the induction of IFNs and some other proinflammatory cytokines. In particular, some TLRs 34 and RLRs, 45 along with PKR 46 and cGAS, 47 trigger signaling events that lead to increased transcription of type 1 IFNs. In turn, type 1 IFNs stimulate production of virus-sensing proteins. For example, IFN-beta promotes transcription of RIG-I, 48 MDA5, 49 and PKR 50,51 by increasing binding of interferon regulatory factor (IRF) 1 to the promoters of these genes. Increased transcription from these genes results in increased production of the corresponding proteins ( Figure 2 ). Thus, RIG-I, MDA5, and PKR are functionally activated by viral RNA, but their transcription is activated by IFN-beta via a positive feedback loop. 48, 52 This autocrine or paracrine signal amplification cycle is crucial for the antiviral protection of cells, but it can be disrupted in cancer cells by various mechanisms.
| Sensors of viral DNA
Among PRRs that sense viral DNA, TLR2 is located in the surface membranes of cells, TLR9 is located in endosomal membranes, 34, 35 and cGAS is a cytosolic PRR. 47 Any serious defect in the TLR receptor circuit disrupts the IFN induction pathway and increases susceptibility to viral infection. For example, in some breast cancer stem cells, the TLR2 receptor is not detectable, whereas TLR9 is associated with endoplasmic reticulum (ER) and Golgi-like structures instead of endosomes. Consequently, in such cells, the virus is unable to induce expression of IFN-alpha, IFN-beta, or signal transducer and activator of transcription protein 1 (STAT1). Deficiency of these components promotes sensitivity of cells to adenovirus infection. 15 Type 1 IFN response is triggered by cGAS though activation of secondary messengers ( Figure 3 ). 47 Epigenetic silencing of the cGAS gene was found in some melanoma cell lines. These cell lines were highly susceptible to herpes simplex virus 1 (HSV1) and vaccinia virus. 17 
| Sensors of viral RNA
Among PRRs that sense viral RNA are TLR3, TLR7/8, 34 RLRs, [53] [54] [55] PKR, 33 RNase L, 56 and representatives of the 2′-5′-OAS enzyme family. 41 All of these proteins are functionally activated by viral RNAs and initiate signaling cascades ( Figure 4 ) that trigger type 1 IFN production and limit virus spread.
Toll-like receptors that recognize viral RNAs might be located in cell surface membranes (TLR3) or in endosomal membranes (TLR7/ 8). Sensitivity of primary prostatic adenocarcinoma cell lines to Sendai virus inversely correlates with expression levels of TLR3 and TLR7
mRNA. Cell lines with lower expression levels of these TLRs were more sensitive to virus infection. 16 Retinoic acid-inducible gene-I-like receptors include protein products of RIG-I and MDA5 genes. These proteins are RNA helicases that are ubiquitously expressed in most tissues. [53] [54] [55] Retinoic acid-inducible gene-I is a cytosolic viral RNA-sensing protein that is functionally activated after its interaction with ssRNAs containing 5′-triphosphate or with dsRNAs shorter than 1 kb 57, 58 ( Figure 4) . Several studies suggest a contribution of RIG-I deficiency to virus-mediated oncolysis. In multiple myeloma, glioblastoma, and astrocytoma derived cells, the ability of Newcastle disease virus (NDV) to induce the expression of RIG-I is critical for resistance to viral infection. 59 Similar results were obtained in another study, in which normal cells were compared with sarcoma, breast adenocarcinoma, and macrophage-derived tumor cells. A negative correlation FIGURE 2 Interferon (IFN) signal amplification loop. RIG-I, MDA5, and PKR are functionally activated by viral RNAs. After activation, they trigger signaling cascades that result in increased production and secretion of type 1 IFNs. In turn, secreted IFN-beta interacts with intramembrane receptors of the cell in which it was produced or of another cell. Such interaction initiates autocrine or paracrine downstream signaling pathways, resulting in increased binding of IRF1 to promoters of RIG-I, MDA5, and PKR. Such binding stimulates transcription of these genes and ultimately increases production of the relevant proteins FIGURE 3 cGAS viral DNA sensor and its downstream signaling. GMP-AMP synthase (cGAS) is a cytosolic sensor of viral DNA that, after activation by foreign DNA, triggers a type 1 IFN response. cGAS forms a complex with adaptor protein STING, which promotes phosphorylation of interferon regulatory factors 3 and/or 7 (IRF3 and/or IRF7). Phosphorylated IRF3 and IRF7 relocate from the cytoplasm to the nucleus, where they trigger type 1 IFN production. Malfunction of cGAS, STING, IRF3, or IRF7 disrupts downstream IFN production pathways, making cancer cells vulnerable to oncolytic virus infection was found between the efficiency of viral oncolysis and constitutive or NDV-stimulated expression of RIG-I. 29, 60 Retinoic acid-inducible gene-I downstream signaling is blocked in some RAS transformed cells. The block causes susceptibility to reovirus infection, whereas overexpression of RIG-I restores virus resistance. 18 It has also been demonstrated that resistance to measles virus positively correlates with viral ability to initiate the expression of RIG-I in sarcoma cell lines. This expression was strong in resistant and weak in susceptible cell lines. 19 Melanoma differentiation-associated protein 5 is a cytosolic viral RNA sensing protein that is activated after interaction with dsRNAs larger than 1 kb 55 (Figure 4 ). Impaired expression of the MDA5 gene Protein kinase R is a cytosolic RNA-sensing protein that is activated by viral dsRNAs of variable length. During the activation process, PKR undergoes autophosphorylation and then phosphorylates the translation initiation factor eIF2α ( Figure 4 ), leading to arrested translation of both cellular and viral mRNAs and even to apoptosis. 42, 43 Protein kinase R also participates in a signal transduction pathway that further upregulates IFN-beta transcription 46 (Figure 4 ).
By these mechanisms, the activated PKR restrains virus replication.
Similar to RIG-I and MDA5 genes, the transcription of PKR mRNA is activated by type 1 IFNs, forming a self-activation regulatory loop. 50, 51 Malignant progression often leads to impaired PKR function. 61 Truncations of the PKR gene have been observed in many leukemia cell lines. 62 Moreover, in most of the leukocyte samples from patients with chronic B-cell leukemia, PKR enzymatic activity was undetectable, despite the presence of a full-length PKR gene. 62 Decreased levels of PKR expression were found in samples obtained from patients with chronic lymphocytic leukemia 63 and nonsmall cell lung cancer. [64] [65] [66] Low levels of PKR expression were also associated with higher incidence of disease relapse and reduced overall survival of patients with rectal cancers. 67 In breast cancer samples, substantial decrease in PKR functional activity was also observed, despite an increase in its expression. 68 In response to viral infection, cancer cells with low or absent PKR activity could not induce eIF2α phosphorylation and IFN-beta transcription, resulting in increased NDV replication. 21 Ribonuclease L is another cytosolic sensor of viral RNAs. 56 prostate cancer samples [70] [71] [72] and are also associated with a predisposition to prostate cancer. 73 A decrease in RNase L activity was also observed in lung cancer. 74 There is some evidence that impaired RNase L function affects the sensitivity of cancer cells to oncolytic viruses. It was shown that the chemical compound sunitinib promotes infection with vesicular stomatitis virus (VSV) and negatively affects the functions of PKR and RNase L. In ovarian, prostate, and renal cell carcinoma cell lines, sunitinib inhibited RNase L enzymatic activity. In a mouse model, simultaneous sunitinib and VSV treatments led to complete elimination of prostate, breast, and kidney tumors, followed by the animals' recovery. 22 The family of OAS enzymes is represented by 3 genes: OAS1, OAS2, and OAS3. All members of the family are cytosolic viral RNA sensors that are functionally activated by viral dsRNAs 41 and transcriptionally activated by type 1 IFNs. 50, 51 During viral infection, OAS3 activates latent RNase L (Figure 4 ), whereas OAS 1 and OAS2 have other antiviral functions. 41 Without OAS3 activation, RNase L does not sense viral RNAs. 41 Oligoadenylate synthetase dysfunction is connected with carcinogenesis: Polymorphism of OAS1 is associated with prostate cancer 75 ; low or absent OAS2 expression characterizes some pancreatic cancers 23 ; and polymorphism of OAS3, which decreases its gene expression level, is associated with risk of chronic lymphocytic leukemia. 76 It has been shown that defective The pairing adaptor for cGAS is the stimulator of IFN genes (STING) protein, also known as transmembrane protein TMEM173 or MITA (Figure 3) . Stimulator of IFN genes is located on the ER and/or the mitochondria-associated ER membranes. 79 In some tumors, immune adaptor proteins' expression and/or activity is deregulated.
Thus, STING function is disabled in numerous colorectal adenocarcinomas. This loss of function is highly predictive of HSV1-mediated oncolytic activity. 24 Melanoma cells often lose STING signaling through the epigenetic silencing of either STING or cGAS genes.
Because of this loss, these cells are unable to produce type 1 IFNs in response to DNA viruses and are highly susceptible to HSV1 and vaccinia virus. 17 
| ANTIVIRAL IRFs
Antiviral IRFs belong to a family of transcription factors that control many cellular processes, including the induction of antiviral cytokines and type I IFNs. Viral nucleic acid sensors such as TLR3/7/8/9, 34 RLRs, 55 PKR, 46 and cGAS, 47 by interacting with adaptor proteins, initiate phosphorylation of IRF3 and/or IRF7 (Figures 3 and 4 ). 80 This phosphorylation promotes IRF3 and/or IRF7 translocation from cytoplasm to nucleus. In the nucleus, these phosphorylated IRFs trigger transcription of type 1 IFNs, which initiate autocrine and paracrine loops of signal amplification. Interferon-beta stimulates transcription of viral RNA sensors such as RIG-I, 48 MDA5, 49 and PKR 51 by increasing the binding of IRF1 to promoter regions of these genes. Thus, on the one hand, IRFs could be activated by virus-sensing proteins; on the other hand, IRFs promote the signal amplification process, leading to the activation of transcription from the genes encoding the virussensing proteins (Figure 2 ). As documented below, aberrant expression of IRFs, which characterizes many cancers, 81 contributes to viral oncolysis.
Interferon regulatory factor 1 is a transcription factor that activates transcription of the genes containing IFN-stimulated response elements. Viral nucleic acid-sensing proteins such as RIG-I, MDA5, and PKR are among these genes. Interferon regulatory factor 1 also participates in the upregulation of many genes that restrain cell proliferation and exert antitumor effects. 82 In cancer cells, the transcription activation function of IRF1 is often disabled. So, in acute myeloid leukemias 83 and gastric cancers, 84 the IRF1 gene is frequently deleted or silent; in many breast 85, 86 and invasive hepatocellular carcinomas, 87 its expression is low or absent.
In cancer cells, IRF1 function can be suppressed by an activated
Ras-Raf-MEK-ERK pathway. Specifically, activated MEK inhibits IRF1 binding to target promoter binding sites and suppresses transcription of viral RNA sensing genes. This inhibition often occurs in malignant cells, which on the one hand eliminates the antiproliferative constraints of IRF1-controlled genes, and on the other makes the cells vulnerable to viral infection. MEK inhibitors restore transcription of IRF1-controlled genes. 82 It was also shown that a permanently activated Ras-Raf-MEK-ERK pathway not only suppresses IRF1 transcriptional activity but also inhibits the function of IRF1 as such, whereas MEK inhibitors restore it. 82 The comparison of normal and malignant macrophage derived cells demonstrated that basal and NDV-induced expression levels of IRF3 and IRF7 were reduced in cancer cells. Because the IRF3-IRF7 complex triggers transcription of type 1 IFNs, reduced levels of the complex are associated with low levels of type 1 IFNs, which are insufficient for protection against viruses. In cancer cells, a negative correlation was found between NDV sensitivity and the basal expression levels of IRF3, IRF7, and IFN-beta. 29 In lung cancer cell lines, IRF7
and/or IRF5 epigenetic silencing were associated with high VSV sensitivity. In cells that were the most sensitive to VSV, promoters of both IRF5 and IRF7 were hypermethylated. Moreover, experimental knockdown of IRF5 and IRF7 by siRNAs increased cell susceptibility to viral infection. In contrast, IRF5 and IRF7 overexpression reduced this susceptibility. 30 The phosphatase and tensin homolog (PTEN) acts as a tumor suppressor gene and participates in IRF3 import into the nucleus, which is required for the transcription activation of IFN genes. 41 Therefore, it plays a critical role in antiviral innate immunity. 90 Phosphatase and tensin homolog tumor suppressor gene is commonly inactivated by mutations or deletions in human cancers, 91 resulting in VSV sensitivity. 32 
| DEFECTIVE IFN RESPONSE IN MALIGNANT CELLS
The type 1 IFN response pathway, schematically shown in Figure 5 , is triggered by interaction of either IFN-alpha or IFN-beta with a receptor on the cell surface. The receptor consists of a complex of 2 transmembrane subunits, the products of the IFNAR1 and IFNAR2 genes. 92 After the interaction, the complex activates receptor-associated Janus kinase (JAK) 1 and tyrosine kinase 2. The kinases phosphorylate the STAT1 and STAT2 proteins, which form a dimer and interact with IFN-regulatory factor 9 (also known as p48) to form a trimolecular complex called IFN-stimulated gene factor 3.
IFN-stimulated gene factor 3 moves to the nucleus and activates the transcription of interferon-stimulated genes 92 (Figure 5) . Interferonstimulated genes encode a family of proteins that inhibit multiple stages of a viral infection, including virus entry, translation, replication, assembly, and dissemination. 93 Other types of IFNs employ different receptor molecules, although their signal transduction pathways utilize similar JAK kinase and STAT proteins. Janus kinase 1 participates in type 1 and type 3 IFN signaling, while JAK2 participates only in the type 2 IFN signaling cascade. 94, 95 An impaired IFN response pathway is a common defect in cancer cells. The genes that belong to the pathway whose defects were shown to be associated with sensitivity to viral oncolysis are described below and listed in Table 2 .
| IFN RECEPTORS
Low expression levels of IFNAR1 and/or IFNAR2 protein and/or mRNA are characteristic of different malignancies, including melanomas, 104 mesotheliomas, 31 and carcinomas of hepatocellular, 9,10 pancreatic, 11 and gastric 12 origin. IFNAR1 expression was also missing in approximately 25% of 48 mesothelioma tumor biopsies. 31 In addition, low IFNAR protein levels are common in various bladder cancer cell lines and in clinical samples of bladder tumors. IFNAR expression level FIGURE 5 IFN-alpha and IFN-beta response pathways. Type 1 IFN response is triggered by a cell surface receptor represented by a complex of 2 transmembrane subunits IFNAR1 and IFNAR2. After interaction with IFN-alpha or IFN-beta, the complex activates receptor-associated Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK 2). The kinases phosphorylate the signal transducer and activator of transcription 1 (STAT1) and STAT2 proteins. These phosphorylated proteins (STAT1 and STAT2), in the form of a dimer, interact with IFN-regulatory factor 9 (IRF9, also known as p48) and form a trimolecular complex called IFN-stimulated gene factor 3. Interferon-stimulated gene factor 3 relocates from the cytoplasm to the nucleus, where it activates transcription of interferon stimulated genes. Interferon stimulated genes encode a family of proteins that inhibit multiple stages of viral infection, including virus entry, translation, replication, assembly, and spread. Malfunction of IFNAR1, IFNAR2, JAK1, STAT1, STAT2, and/or IRF9 disrupts transcription of IFN-stimulated genes, making cancer cells vulnerable to oncolytic virus infection correlated with tumor grade: The content of IFNAR was relatively high in more differentiated tumors and relatively low in less differentiated tumors. 96 IFNAR expression levels also correlated with cell sensitivity to viral infection. It was shown that in primary macrophages, deletion of the IFNAR1 gene was associated with NDV susceptibility. 60 In mesothelioma cell lines, which were sensitive to VSV, IFNAR1 and/ or IFNAR2 expression were significantly downregulated or undetectable. 31 In bladder carcinoma cell lines, an inverse correlation was found between the inhibition of cellular proliferation induced by type 98 there was no expression or functional activation of STAT1. In chronic lymphocytic leukemia, STAT1 and STAT3 phosphorylation was impaired. 108 In some prostate cancers, JAK1 expression was not detected, 109 while in some leukemias and lymphomas, disabling mutations or chromosomal rearrangements of JAK 1 and/or JAK2 have been observed. [110] [111] [112] [113] There is a relation between JAK/STAT pathway dysfunction and virus sensitivity. Janus kinase 1/2 inhibitors make cancer cells sensitive to VSV infection. Treatment of virus-resistant head and neck cancer cells with these inhibitors before or simultaneously with administration of VSV enhanced the spread of infection and increased the virus progeny yield by few orders of magnitude. 97 Similarly, treatment of VSV-resistant pancreatic ductal adenocarcinoma cells with JAK1/2 inhibitor promoted VSV sensitivity. 23 In fibrosarcoma cells, a defect in the IFN response pathway at the level of STAT protein promotes the cells' NDV sensitivity. Phosphorylation of STAT1 and STAT2 that occurs in normal fibroblasts in response to IFN treatment was not detected in these cells. Moreover, pretreatment of these cells with IFN-beta induced a much smaller number of IFN-stimulated genes and did not inhibit NDV spread. 99 Similar observations were made in prostate cancer cells with respect to their susceptibility to respiratory syncytial virus. Unlike normal prostate cells, prostate cancer cells could not activate STAT1 transcription, despite their ability to induce IFN production in response to respiratory syncytial virus. It was concluded that a defect in the IFN response pathway at the level of STAT1 protein led to VSV sensitivity. 98 Similarly, STAT1 experimental knockdown rendered hepatocellular carcinoma cells susceptible to Sindbis virus. 20 Low expression Adenovirus 5 and adenoassociated viruses 5 and 6 103 More examples of the relationship between a deficient JAK/STAT pathway and viral oncolysis were found in studies with mesothelioma and sarcoma cells. Vesicular stomatitis virus-sensitive mesothelioma cells, in addition to reduced expression levels of IFNAR1 and/or IFNAR2 mRNA, also displayed downregulation of one or several transcripts of STAT1, STAT2, JAK1, tyrosine kinase 2, PKR, and IFN-regulatory factor 9 (p48). 31 It also has been shown that measles virus-sensitive sarcoma cells exhibit weak, delayed, or only transient phosphorylation of STAT1 and weak or undetectable expression of IFN-induced protein with tetratricopeptide repeats 1. 19 In another study, a decrease in IFN-induced phosphorylation of STAT1 and STAT2 proteins was observed when the Ras-Raf-MEK-ERK pathway was activated. Moreover, in cells with the activated pathway, the total amount of STAT2 was reduced. However, STAT2
overexpression partially restored the transcription of IFN-induced genes along with VSV resistance. 100 It is sometimes difficult to distinguish whether cancer cell sensitivity to viruses is caused by defects in the IFN induction or IFNresponse pathways. For example, it was found that differences in the sensitivity of melanoma cell lines to VSV were associated with a mutation in the B-RAF gene, a representative of the RAF serine/threonine specific protein kinase family and a participant in the Ras-Raf-MEK-ERK pathway. 101 The mechanism that underlies this sensitivity
is not yet known, and it is not clear if the mutation is associated with downregulation of genes involved in type 1 IFN induction or response pathways.
| IFN STIMULATED GENES
The products of the MX genes are proteins with a protective function against both RNA and DNA viruses. Most mammals have two MX genes, MX1 and MX2, whose protein products are called MxA and MxB. 114 Mx proteins bind GTP and act as GTPases. 115 In the pleural mesothelioma cell lines that were most VSV sensitive, neither basal nor IFN-beta stimulated expression of MxA, PKR, and OAS was detected. However, in cell lines that were less sensitive to VSV, IFN-beta treatment stimulated, to various degrees, transcription from these genes. 31 Thus, IFN-beta treatment response, in the form of induction of MxA, PKR, and OAS transcription, correlates with VSV sensitivity.
A relationship was also found between the expression of GBP1, XAF1, and/or EPSTI1 genes and viral oncolysis in pancreatic ductal adenocarcinoma cells. These genes were constitutively expressed in VSV resistant cells and were not expressed at all in VSV-sensitive cells. 102 
| DIRECTIONS FOR FUTURE RESEARCH
There are genes that are not involved in the IFN signaling pathway, whose expression is necessary for a productive viral infection of tumor cells ( Figure 6) . 
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FIGURE 6
Host requirements for viral infection of tumor cells. For productive infection, viruses require cell to express virus receptors and to have a malfunctioning IFN pathway. Some virus families also require cells to express processing enzymes, without which infective virions cannot be formed
